Personalis, Inc.

( )
PSNL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -2.41%128.060.0%$1284.86m
OCGNOcugen, Inc. -0.10%10.450.0%$1252.81m
NVAXNovavax, Inc. -2.80%178.4792.9%$701.03m
AMGNAmgen, Inc. 0.00%223.941.3%$548.96m
VRTXVertex Pharmaceuticals, Inc. -0.93%206.501.9%$514.03m
REGNRegeneron Pharmaceuticals, Inc. -0.61%444.002.7%$500.11m
GILDGilead Sciences, Inc. -0.05%62.721.0%$479.84m
ILMNIllumina, Inc. -0.34%415.003.5%$474.87m
ALXNAlexion Pharmaceuticals, Inc. 0.00%148.192.0%$341.53m
BIIBBiogen, Inc. 0.00%266.601.7%$320.42m
BNGOBionano Genomics, Inc. -7.02%7.950.0%$281.16m
CRSPCRISPR Therapeutics AG -1.75%117.000.6%$277.99m
EXASEXACT Sciences Corp. -0.41%126.0518.4%$235.07m
SGENSeagen Inc. 0.00%147.935.8%$209.02m
PACBPacific Biosciences of California, Inc. -3.47%29.897.2%$158.14m

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.